Flow Neuroscience announced that the FDA approved its Flow at-home brain stimulation device for treating major depressive ...

The R&D pipeline for depression therapies faced a demoralizing 2025 as five high-profile candidates, including KOR ...

High placebo responses common in tests of neuropsychiatric drugs make any clinical trial in major depressive disorder risky. Intra-Cellular Therapies now has data showing its drug met key goals of a ...

A new analysis shows that anti-inflammatory medications may help reduce symptoms for a subset of people with depression who ...

Q. I developed severe depression while taking Repatha, the injectable cholesterol-lowering drug. It took me a horrible nine months to realize the drug was making me suicidal. If I wasn’t sleeping, I ...

Health Canada has approved the first drug designed to treat postpartum depression. The regulator says zuranolone, a pill sold ...

There's a well-established link between depression and chronic low-grade inflammation. Now, a new meta-study shows that ...

I was in my second year of medical school when Solomon Snyder, a professor of neuroscience at Johns Hopkins Medical School, presented to our class his revolutionary work in brain chemistry and ...

LONDON, Dec 7 (Reuters) - Patients with depression who fail to benefit from antidepressant drugs may do better if they are also treated with a type of "talking" psychotherapy called CBT, according to ...

A much-awaited treatment for postpartum depression, zuranolone, hit the market in December, promising an accessible and fast-acting medication for a debilitating illness. But most private health ...

Nigel Mulligan does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...